Adjuvant Immunotherapy with BCG in Squamous-cell Bronchial Carcinoma. Immune-reactivity in Relation to Immunostimulation (preliminary Results in a Controlled Trial)

Overview

Journal Thorax

Date 1978 Aug 1

PMID 358479

Citations 5

Authors

H M Jansen

T H The

G C de Gast

M T Esselink

A M van der Wal

N G ORIE

Affiliations

Soon will be listed here.

Citing Articles

Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention.

Jadus M, Natividad J, Mai A, Ouyang Y, Lambrecht N, Szabo S Clin Dev Immunol. 2012; 2012:160724.

PMID: 22899945 PMC: 3414063. DOI: 10.1155/2012/160724.

Immunotherapy in lung cancer.

Al-Moundhri M, OBrien M, Souberbielle B Br J Cancer. 1998; 78(3):282-8.

PMID: 9703271 PMC: 2063029. DOI: 10.1038/bjc.1998.486.

Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.

Jansen H, The T, ORIE N Thorax. 1980; 35(10):781-7.

PMID: 7466726 PMC: 471380. DOI: 10.1136/thx.35.10.781.

Postoperative intrapleural BCG in lung cancer: lack of efficacy and possible enhancement of tumour growth.

Bakker W, Wever A, Brutel de la Riviere A, van der Velde E, Dijkman J Thorax. 1981; 36(11):870-4.

PMID: 7330812 PMC: 471833. DOI: 10.1136/thx.36.11.870.

Adjuvant chemotherapy and immunotherapy for colorectal cancer: preliminary communication.

Bancewicz J, Calman K, Macpherson S, McArdle C, McVie J, Soukop M J R Soc Med. 1980; 73(3):197-9.

PMID: 7014886 PMC: 1437544. DOI: 10.1177/014107688007300308.

References

Gehan E . A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. Biometrika. 1965; 52:203-23. View

Holmes E, Ramming K, Mink J, COULSON W, Morton D . New method of immunotherapy for lung cancer. Lancet. 1977; 2(8038):586-7. DOI: 10.1016/s0140-6736(77)91431-3. View

Hersh E, Mavligit G, Gutterman J . Immunotherapy as related to lung cancer: a review. Semin Oncol. 1974; 1(3):273-8. View

McKneally M, Maver C, KAUSEL H . Intrapleural B.C.G. immunostimulation in lung cancer. Lancet. 1977; 1(8011):593. DOI: 10.1016/s0140-6736(77)92015-3. View

Herberman R, Campbell Jr D, Oldham R, Bonnard G, Ting C, HOLDEN H . Immunogenicity of tumor antigens. Ann N Y Acad Sci. 1976; 276:26-44. DOI: 10.1111/j.1749-6632.1976.tb41634.x. View

Bast R, Bast B . Critical review of previously reported animal studies of tumor immunotherapy with nonspecific immunostimulants. Ann N Y Acad Sci. 1976; 277(00):60-93. DOI: 10.1111/j.1749-6632.1976.tb41692.x. View

Yamamura Y, Azuma I, Taniyama T, Sugimura K, Hirao F, TOKUZEN R . Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results. Ann N Y Acad Sci. 1976; 277(00):209-27. DOI: 10.1111/j.1749-6632.1976.tb41699.x. View

Evans D . Immunology of bronchial carcinoma. Thorax. 1976; 31(5):493-506. PMC: 470466. DOI: 10.1136/thx.31.5.493. View

Mastrangelo M, Berd D, Bellet R . Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulants. Ann N Y Acad Sci. 1976; 277(00):94-123. DOI: 10.1111/j.1749-6632.1976.tb41693.x. View

10.

Stott H, Stephens R, Fox W, Roy D . 5-year follow-up of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus. Br J Cancer. 1976; 34(2):167-73. PMC: 2025161. DOI: 10.1038/bjc.1976.139. View

11.

SHIBATA H, Jerry L, Lewis M, Mansell P, Capek A, MARQUIS G . Immunotherapy of human malignant melanoma with irradiated tumor cells, oral Bacillus Calmette-Guérin, and levamisole. Ann N Y Acad Sci. 1976; 277(00):355-66. DOI: 10.1111/j.1749-6632.1976.tb41714.x. View

12.

Scott M, Bomford R . Comparison of the potentiation of specific tumor immunity in mice by Corynebacterium parvum or BCG. J Natl Cancer Inst. 1976; 57(3):555-9. DOI: 10.1093/jnci/57.3.555. View

13.

Bleumink E, Nater J, Schraffordt Koops H, The T . A standrard method for DNCB sensitization testing in patients with neoplasms. Cancer. 1974; 33(4):911-5. DOI: 10.1002/1097-0142(197404)33:4<911::aid-cncr2820330404>3.0.co;2-b. View

14.

Gutterman J, Mavligit G, McBride C, Frei 3rd E, Freireich E, Hersh E . Active immunotherapy with B.C.G. for recurrent malignant melanoma. Lancet. 1973; 1(7814):1208-12. DOI: 10.1016/s0140-6736(73)90526-6. View

15.

Jondal M, Holm G, Wigzell H . Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972; 136(2):207-15. PMC: 2139198. DOI: 10.1084/jem.136.2.207. View

16.

Israel L . Non-specific immunostimulation in bronchogenic cancer. Scand J Respir Dis Suppl. 1974; 89:95-105. View

17.

MATHE G . Active immunotherapy. Adv Cancer Res. 1971; 14:1-36. DOI: 10.1016/s0065-230x(08)60517-5. View

18.

AUNGST C, Sokal J, JAGER B . Complications of BCG vaccination in neoplastic disease. Ann Intern Med. 1975; 82(5):666-9. DOI: 10.7326/0003-4819-82-5-666. View

19.

Anthony H, Kirk J, Madsen K, MASON M, Templeman G . E and EAC rosetting lymphocytes in patients with carcinoma of bronchus. II. A sequential study of thirty patients: effect of BCG. Clin Exp Immunol. 1975; 20(1):41-54. PMC: 1538175. View

20.

McKneally M, Maver C, KAUSEL H . Regional immunotherapy of lung cancer with intrapleural B.C.G. Lancet. 1976; 1(7956):377-9. DOI: 10.1016/s0140-6736(76)90212-9. View